91 related articles for article (PubMed ID: 32801441)
1. Idiopathic Membranous Nephropathy and Treatment Related Complications.
Uncanin S; Dzemidzic J; Serdarevic N; Muslimovic A; Haskovic D
Med Arch; 2020 Jun; 74(3):228-232. PubMed ID: 32801441
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
[TBL] [Abstract][Full Text] [Related]
3. Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.
Xu C; Xu T; Liu N; Liu L; Sun L; Li X; Li Z; Yao L
Int Urol Nephrol; 2024 Feb; 56(2):699-706. PubMed ID: 37480482
[TBL] [Abstract][Full Text] [Related]
4. Membranous nephropathy in children: clinical presentation and therapeutic approach.
Menon S; Valentini RP
Pediatr Nephrol; 2010 Aug; 25(8):1419-28. PubMed ID: 19908069
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic membranous nephropathy and synchronous mononeuritis multiplex secondary to idiopathic small vessel vasculitis.
Jayanatha K; Kumar A; Sapsford M; Simpson M
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38423575
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio is an independent risk factor for proteinuria non-remission in idiopathic membranous nephropathy.
Zhuo N; Wang G; Wu G
Int Urol Nephrol; 2024 May; 56(5):1775-1776. PubMed ID: 37919620
[No Abstract] [Full Text] [Related]
7. Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy.
Furuto Y; Hashimoto H; Namikawa A; Morikawa T; Shibuya Y
Intern Med; 2023 Nov; 62(21):3175-3181. PubMed ID: 36927975
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.
Zhang N; Jiang H; Dai H; Huang S; Zhao Q; Zhang N; Liu W; Dong Z; Gao Y; Dong X; Hu Y; Hou F; Rui H; Liu Q; Liu B
Ren Fail; 2024 Dec; 46(1):2320834. PubMed ID: 38482580
[TBL] [Abstract][Full Text] [Related]
9. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study.
Rui M; Jiang L; Pan JJ; Huang XT; Cui JF; Zhang SJ; He SM; Han HH; Chen X; Wang DD
Int Urol Nephrol; 2024 Apr; ():. PubMed ID: 38642210
[TBL] [Abstract][Full Text] [Related]
10. NELL-1-associated membranous nephropathy linked to skin fairness cream use: insights from an Indian case series.
Narayanan R; Sivadas S; Kurien AA
Kidney Int; 2024 Jun; 105(6):1316-1319. PubMed ID: 38615743
[No Abstract] [Full Text] [Related]
11. Membranous nephropathy associated with gastrointestinal stromal tumour: a case report.
Cimic A; Pastan SO; Bijol V
NDT Plus; 2009 Aug; 2(4):306-8. PubMed ID: 25984023
[TBL] [Abstract][Full Text] [Related]
12. Urinary single-cell sequence analysis of the urinary macrophage in different outcomes of membranous nephropathy.
Liu X; Zhao Y; Niu Y; Xie Q; Nie H; Jin Y; Zhang Y; Lu Y; Zhu S; Zuo W; Yu C
Clin Kidney J; 2023 Dec; 16(12):2405-2416. PubMed ID: 38046013
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.
Choi JY; Chin HJ; Lee H; Bae EH; Chang TI; Lim JH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH;
PLoS One; 2020; 15(10):e0240566. PubMed ID: 33035278
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis.
Huang L; Dong QR; Zhao YJ; Hu GC
Int Urol Nephrol; 2021 Jan; 53(1):111-119. PubMed ID: 32944889
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy in a patient diagnosed with IgG4-related disease: A case report.
Ma X; Xu H; Sun JY; Gedara YSS; Sun F
Medicine (Baltimore); 2020 Oct; 99(42):e22817. PubMed ID: 33080759
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy in patients with HIV: a report of 11 cases.
Charu V; Andeen N; Walavalkar V; Lapasia J; Kim JY; Lin A; Sibley R; Higgins J; Troxell M; Kambham N
BMC Nephrol; 2020 Sep; 21(1):401. PubMed ID: 32948130
[TBL] [Abstract][Full Text] [Related]
17. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
Berchtold L; Letouzé E; Alexander MP; Canaud G; Logt AV; Hamilton P; Mousson C; Vuiblet V; Moyer AM; Guibert S; Mrázová P; Levi C; Dubois V; Cruzado JM; Torres A; Gandhi MJ; Yousfi N; Tesar V; OndrejViklický ; Hourmant M; Moulin B; Rieu P; Choukroun G; Legendre C; Wetzels J; Brenchley P; Ballarín Castan JA; Debiec H; Ronco P
Kidney Int; 2021 Mar; 99(3):671-685. PubMed ID: 32889013
[TBL] [Abstract][Full Text] [Related]
18. COVİD-19 infection in a membranous nephropathy patient treated with rituximab.
Elcioglu OC; Artan AS; Mirioglu S; Gursu M; Durdu B; Meric Koc M; Okyaltirik F; Gultekin MA; Kazancioglu R
CEN Case Rep; 2021 Feb; 10(1):83-87. PubMed ID: 32888168
[TBL] [Abstract][Full Text] [Related]
19. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G; Rojas-Rivera J; Logt AV; Justino J; Sevillano A; Caravaca-Fontán F; Ávila A; Rabasco C; Cabello V; Varela A; Díez M; Martín-Reyes G; Diezhandino MG; Quintana LF; Agraz I; Gómez-Martino JR; Cao M; Rodríguez-Moreno A; Rivas B; Galeano C; Bonet J; Romera A; Shabaka A; Plaisier E; Espinosa M; Egido J; Segarra A; Lambeau G; Ronco P; Wetzels J; Praga M;
Kidney Int; 2021 Apr; 99(4):986-998. PubMed ID: 33166580
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of thrombotic complications and their outcomes in Chinese children with primary nephrotic syndrome.
Lv YL; Guan N; Ding J; Yao Y; Xiao HJ; Zhong XH; Wang F; Liu XY; Zhang HW; Su BG; Xu K
Ital J Pediatr; 2020 Dec; 46(1):182. PubMed ID: 33298123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
